亚盛医药部分行使超额配股权,融资约1.425亿美元

DoNews
08 Feb

2月7日,亚盛医药 - B (06855) 发布公告,宣布包销商已部分行使其在美国初步公开发售中的超额配股权。此次超额配股权按每股美国存托股份17.25美元减去包销折扣及佣金的价格,购买了935,144股额外美国存托股份。每股美国存托股份代表公司四股普通股。因此,公司在发售中出售的美国存托股份总数增加至8,260,144股,预计所得款项总额约为1.425亿美元(未扣除相关费用)。值得注意的是,从...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10